日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

X-chromosome-linked miR-542-5p as a key regulator of sex disparity in rats with adjuvant-induced arthritis by promoting Th17 differentiation

X染色体连锁的miR-542-5p通过促进Th17分化,在佐剂诱导的关节炎大鼠中发挥性别差异的关键调控作用

Yang, Jiu Jie; Li, Zhi; Wang, Lin Na; Huang, Bai Xiong; Ng, Jerome P L; Xu, Xiong Fei; Wang, Yu Ping; Zhang, David Wei; Qin, Bo; Zhang, Ding Qi; Liu, Chang; Luo, Wei Dan; Law, Betty Yuen Kwan; Wang, Hui Miao; Liu, Meng Han; Yun, Xiao Yun; Chan, Joyce Tsz Wai; Wu, Wan Yu; Li, Yi Ting; Cheung, Peter Kam Fai; Pou, Man Chon; Ha, Kat Sang; Ao Ieong, Wang Fai; Leong, Chi Hou; Leong, Kit Ieng; Lei, Chan Wang; Cheang, Lek Hang; Wong, Vincent Kam Wai

TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway

TFAP2A 通过促进 ESR2 介导的 MAPK 通路来驱动非小细胞肺癌 (NSCLC) 进展和对靶向治疗的抵抗

Ding-Guo Wang #, Jian Gao #, Jing Wang #, Kun-Chao Li, Zhi-Bo Wu, Zhong-Min Liao, Yong-Bing Wu

ZCCHC13-mediated induction of human liver cancer is associated with the modulation of DNA methylation and the AKT/ERK signaling pathway

ZCCHC13 介导的人类肝癌诱导与 DNA 甲基化和 AKT/ERK 信号通路的调节有关

Zhiming Li, Zhi Li, Linjun Wang, Chen Long, Zaozao Zheng, Xuan Zhuang

Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial

高危鼻咽癌患者接受标准放化疗联合同步及辅助卡瑞利珠单抗治疗:一项多中心、随机、开放标签的3期临床试验

You, Rui; Xu, Gui-Qiong; Ding, Xi; Liang, Jin-Hui; Liu, Zhi-Gang; Zou, Xiong; Liu, You-Ping; Hu, Guang-Yuan; Liu, Yi-Min; Duan, Chong-Yang; Liu, Li-Zhi; Zhang, Wei-Jing; Liu, Qian; Li, Hui-Feng; Ouyang, Yan-Feng; Duan, Xiao-Tong; Wang, Qin; Peng, Lan; Liang, Jiong-Lin; Feng, Zheng-Kai; Qin, Zi-Han; Liu, Xiao; He, Zhi-Kun; Zhang, Bin; Long, Guo-Xian; Jiang, Yan-Hui; Lei, Feng; Huang, Pei-Yu; Hua, Yi-Jun; Chen, Ming-Yuan

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial

鼻咽癌内侧咽后淋巴结区域保留放疗:一项开放标签、非劣效性、多中心、随机3期试验的五年分析

Wang, Shun-Xin; Tao, Ya-Lan; Gao, Tian-Sheng; Zhang, Ning; Zhou, Guan-Qun; Xie, Fang-Yun; Zhang, Yuan; Guo, Rui; Yang, Yi; Li, Yong-Jie; Liang, Shao-Qiang; Zeng, Yue-Can; Lin, Li; Li, Wen-Fei; Liu, Xu; Xu, Cheng; Chen, Yu-Pei; Lv, Jia-Wei; Liu, Li-Zhi; Li, Hao-Jiang; Li, Ji-Bin; Wen, Hong-Mei; Sun, Ying; Tang, Ling-Long; Liang, Xiao-Yu; Ma, Jun; Mao, Yan-Ping

Biomimetic liposomes in drug delivery: from design mechanisms to applications

仿生脂质体在药物递送中的应用:从设计机制到实际应用

Li, Zhi; Li, Mengwen; Lu, Jianqin

Machine learning model on multi-omics data enables risk stratification and identifies molecular heterogeneity and therapeutic targets in glioblastoma

基于多组学数据的机器学习模型能够对胶质母细胞瘤进行风险分层,并识别分子异质性和治疗靶点。

Zhang, Zhenyu; Wang, Zilong; Li, Ran; Pei, Dongling; Liu, Jingdian; Qiu, Yuning; Liu, Zaoqu; Wang, Minkai; Ma, Zeyu; Duan, Wenchao; Wang, Weiwei; Yan, Jing; Guo, Yang; Liu, Haoran; Li, Wenyuan; Yu, Yinhui; Chen, Te; Ma, Caoyuan; Yu, Miaomiao; Fu, Jing; Su, Dingyuan; Li, Sen; Geng, Haotian; Yu, Bin; Zhen, Yingwei; Chen, Ruokun; Sun, Qiuchang; Zhao, Yuanshen; Duan, Jingxian; Zheng, Hairong; Liang, Dong; Liu, Xianzhi; Li, Zhi-Cheng; Ji, Yuchen; Yan, Dongming

Tumor PD-L1 induces β2m ubiquitylation and degradation for cancer cell immune evasion.

肿瘤PD-L1诱导β2m泛素化和降解,从而使癌细胞逃避免疫攻击。

Zhao Qiuling, Li Chenglong, Zhang Mengsi, Gao Tingfang, Wang Zhidong, Li Zhi, Qin Yan, Xue Xinwen, Chen Mengyun, Xu Chengping, Zhang Guozhi, Cui Xiang, Zhang Kangjian, Qi Xiaowei, Bian Xiu-Wu, Yang Yi

mJ-level 7-octave ultraflat white laser encompassing 200-25,000 nm

毫焦耳级7倍频程超平坦白光激光器,波长范围200-25,000纳米

Hong, Lihong; Feng, Renyu; Liu, Yuanyuan; Liu, Junming; Qian, Junyu; Peng, Yujie; Leng, Yuxin; Li, Ruxin; Li, Zhi-Yuan

Infection responsive bio-nanoparticles as "molecular sprayer " for infection-repair integration via direct sterilization and macrophage polarization regulation

感染响应型生物纳米颗粒作为“分子喷雾器”,可通过直接杀菌和巨噬细胞极化调控实现感染修复整合。

Ma, Cheng-Jie; Peng, Zhi; Xu, Rui; Fang, Jun-Hua; Wang, Han-Ying; Yang, Xiong-Gang; Li, Yu-Ling; Zhang, Dong-Yuan; Li, Zhi-Qiang; Zhao, Yu; Hou, Jian-Hong; Lu, Sheng